Skip to content

Exploring the Impact of Dynamic Defocus Display Schemes on Ocular Health Indicators

Exploring the Impact of Dynamic Defocus Display Schemes on Ocular Health Indicators

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07291856
Enrollment
36
Registered
2025-12-18
Start date
2025-08-20
Completion date
2025-11-30
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Visual Fatigue

Keywords

Dynamic Defocus Display Technology, Visual Fatigue, visual function, Repeated Measures Design, Longitudinal Chromatic Aberration

Brief summary

The present study is designed to explore the effects of dynamic defocus display technology on ocular health parameters using rigorous scientific approaches. It further examines the mechanisms through which this technology alleviates visual fatigue, thereby providing robust clinical evidence to support its practical application and widespread adoption.

Detailed description

Research Content Recruit adults who meet the inclusion criteria and have long-term use of VDT (Visual Display Terminal) devices for the trial. Compare the impact of different dynamic defocus modes on the visual fatigue symptoms of the subjects. Analyze the mechanisms through which dynamic defocus modes alleviate visual fatigue. Research Outcome Measures Primary Outcome Measures and Definitions Binocular Visual Function: A series of assessments of visual ability, including accommodative function (amplitude of accommodation, accommodative facility) and vergence function (near point of convergence, AC/A ratio). Secondary Outcome Measures and Definitions Critical Flicker Fusion Frequency (CFF): To evaluate the degree of eye fatigue, with lower measured values indicating a higher degree of fatigue. Visual Fatigue Questionnaire Score: To assess the subjective level of visual fatigue experienced by the subjects. Refraction Results: To monitor changes in refractive status during the trial and evaluate the impact of different dynamic defocus modes on refractive state when using VDT devices at near distance.

Interventions

BEHAVIORALDynamic Defocus Mode

Participants are required to complete a 50-minute video-watching task using a terminal display device that contains video content processed with different dynamic defocus modes. Specifically, participants will watch the same series of videos in different dynamic defocus modes. Participants will complete a total of 5 sets of video tasks (including the control group) in a random order.

Sponsors

Beijing Tongren Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Masking description

In this clinical trial, the masking is applied to the participants and the study staff who conduct the assessments. The participants are single-blinded, meaning they are unaware of the specific dynamic defocus mode they are assigned to during the trial. This is to ensure that their subjective responses, such as those recorded in the visual fatigue questionnaire, are not influenced by their knowledge of the intervention. The study staff who perform the assessments, including the measurement of critical flicker fusion frequency (CFF), accommodative function, and other ocular health indicators, are also blinded to the group assignments. This helps to prevent any potential bias in the data collection process, ensuring that the measurements are objective and reliable. The randomization sequence and group assignments are managed by a third-party institution, which maintains the integrity of the blinding. Only after all data have been collected and the initial analysis is complete will the bl

Intervention model description

This study is designed with a total of five groups, where participants will sequentially and randomly undergo all the intervention procedures.

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Adults aged between 20 and 40 years, regardless of gender; Refractive anisometropia ≤2.5D and corrected visual acuity of 1.0 or above in both eyes; Habitual long-term use of electronic devices with LED light sources, such as computers and smartphones; Currently not using any other blue light protection products or having ceased the use of such products for at least 2 weeks; No known visually significant ophthalmic diseases; Willing to participate in the trial and having signed the informed consent form.

Exclusion criteria

Abnormal accommodative function or other visual function abnormalities (e.g., strabismus, amblyopia); Severe dry eye or history of ocular medication use; Acute or chronic ocular surface inflammation, keratoconus, history of ocular surgery (e.g., refractive surgery), systemic diseases, or other conditions (e.g., wearing orthokeratology lenses and using atropine); Photosensitivity, history of epilepsy, etc.; Individuals unable to cooperate with the examination.

Design outcomes

Primary

MeasureTime frameDescription
Binocular Visual Function(amplitude of accommodation)Baseline (before intervention), immediately after the 50-minute video-watching task for each of the five sessions, totaling ten completions per participant.The amplitude of accommodation refers to the maximum amount of accommodative power that the eye can exert to focus on near objects, typically measured in diopters.
Binocular Visual Function(accommodative facility)Baseline (before intervention), immediately after the 50-minute video-watching task for each of the five sessions, totaling ten completions per participant.Accommodative facility, measured using a 2D flipper in cycles per minute (cpm), reflects the eye's ability to rapidly and efficiently change focus between near and far objects, indicating the dynamic functioning of the accommodative system.

Secondary

MeasureTime frameDescription
Refractive error statusBaseline (before intervention), immediately after the 50-minute video-watching task for each of the five sessions, totaling ten completions per participant.The refractive error status of the subjects was determined using a combination of automatic refractometer and subjective refraction, with results expressed in diopters.
Visual Fatigue Questionnaire ScoreBaseline (before intervention), immediately after the 50-minute video-watching task for each of the five sessions, totaling ten completions per participant.The Computer Vision Syndrome Questionnaire (CVS-Q), which has been independently modified, comprises 16 response items. Participants will complete the questionnaire before and after the task to assess changes in ocular strain symptoms. By comparing the questionnaire scores obtained when using different dynamic defocus modes of the VDT devices, the effectiveness of dynamic defocus modes in alleviating subjective symptoms of ocular strain will be evaluated.
Critical Flicker Fusion Frequency(CFF)Baseline (before intervention), immediately after the 50-minute video-watching task for each of the five sessions, totaling ten completions per participant.To evaluate the degree of eye fatigue, with lower measured values indicating a higher degree of fatigue.

Other

MeasureTime frameDescription
Multispectral refraction topographyBaseline (before intervention), immediately after the 50-minute video-watching task for each of the five sessions, totaling ten completions per participant.Multispectral Refraction Topography (MRT) is an advanced imaging technique used to map the refractive properties of the eye across multiple wavelengths. By analyzing the eye's refractive profile at different spectral ranges, MRT offers a comprehensive understanding of the eye's optical characteristics.
Optical Coherence Tomography AngiographyBaseline (before intervention), immediately after the 50-minute video-watching task for each of the five sessions, totaling ten completions per participant.Optical Coherence Tomography Angiography (OCTA) is a non-invasive imaging technique that provides detailed cross-sectional images of retinal and choroidal structures. It is particularly useful for evaluating the choroidal thickness, which can be measured precisely in micrometers.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026